FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medications and deals with reinforcing agent for radiation therapy, which includes as active ingredient pyridine derivative, represented by general formula (1). Invention also relates to application of pyridine derivative, represented by general formula 
where R1, R2, R3 and R4 have values given in the formula, for obtaining reinforcing agent for radiation therapy and method of radio-therapy of cancer.
EFFECT: application of claimed reinforcing agent for radio-therapy makes it possible to reduce radiation dose and unfavorable side effects when applied in combination with cancer radio-therapy.
15 cl, 4 dwg, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PREPARATION POTENTIATING RADIATION THERAPY | 2007 |
|
RU2435587C2 |
| COMBINED THERAPY FOR CANCER TREATMENT | 2015 |
|
RU2708374C2 |
| NEW DERIVATIVES OF PEG | 2015 |
|
RU2697551C2 |
| ANTITUMOR AGENT AND ANTITUMOR EFFECT AMPLIFIER | 2018 |
|
RU2783759C2 |
| APPLICATION OF TRISUBSTITUTED GLYCEROL COMPOUNDS FOR TREATMENT OF RADIOLESIONS | 2007 |
|
RU2448973C2 |
| CARBORANYLPORPHYRINE AND USE THEREOF | 2007 |
|
RU2477161C2 |
| CANCER CHEMOTHERAPY USING AZABICYCLO COMPOUND | 2018 |
|
RU2821034C2 |
| METHODS FOR COMBINED THERAPY OF MALIGNANT NEOPLASMS USING IRON OXIDE NANOPARTICLES | 2023 |
|
RU2816227C1 |
| AGENT INTENSIFYING ACTION OF ANTI-CANCER AGENTS | 2012 |
|
RU2589713C2 |
| METHOD OF TREATING BREAST CANCER WITH COMPOUND OF 4-IODINE-3-NITROBENZAMINE IN COMBINATION WITH ANTICANCER AGENTS | 2008 |
|
RU2480211C2 |
